5 Ankylosing Spondylitis Clinical Trials in Irving, TX (2026)

Q: How do I join a clinical trial in Irving?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Irving research site will contact you.

Recruiting Ankylosing Spondylitis Studies in Irving

NCT05458219Recruiting

A First-in-human Study of IBI343 in Subjects With Locally Advanced Unresectable or Metastatic Solid Tumors

This is a Phase Ia/Ib, multicenter, open-label, first-in-human study to evaluate the safety, tolerability, PK, and efficacy of IBI343 in participants with locally advanced unresectable or metastatic s...

Irving, TX470 participantsInnovent Biologics (Suzhou) Co. Ltd.

View Study Details

NCT07021898Recruiting

A Study of ERAS-4001 in Patients With Advanced or Metastatic Solid Tumors.

The main purpose of the study is to assess whether the study drug, ERAS-4001, is safe and tolerable when administered to patients with advanced or metastatic solid tumors with certain KRAS mutations. ...

Irving, TX200 participantsErasca, Inc.

View Study Details

NCT07488676Recruiting

A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

This study will help find the most suitable dose of ASP546C in people with gastric cancer, gastroesophageal junction (GEJ) cancer, pancreatic cancer, and other specific solid tumors. GEJ is where the ...

Irving, TX150 participantsAstellas Pharma Global Development, Inc.

View Study Details

NCT07535112Recruiting

A Study to Learn More About How Safe BAY 3771249 is and How Well it Works in People With Advanced or Metastatic Colorectal Cancer That Has a KRAS G12D Mutation

Researchers are looking for a better way to treat people who have advanced or metastatic colorectal cancer (CRC) with a specific mutation, the G12D mutation, in a protein called KRAS. Colorectal canc...

Irving, TX130 participantsBayer

View Study Details

NCT07493512Recruiting

Trial of Xaluritamig in Adults With Metastatic Castration-resistant Prostate Cancer

The primary objective of this trial is to determine the safety profile of xaluritamig at the proposed regimen in adult participants with metastatic castration-resistant prostate cancer (mCRPC)....

Irving, TX40 participantsAmgen

View Study Details

About Ankylosing Spondylitis Clinical Trials in Irving

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 5 ankylosing spondylitis clinical trials recruiting participants in Irving, TX. These studies are seeking a combined 990 participants. Research is being sponsored by Innovent Biologics (Suzhou) Co. Ltd., Erasca, Inc., Astellas Pharma Global Development, Inc. and 2 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Irving — FAQ

Are there ankylosing spondylitis clinical trials in Irving?

Yes, there are 5 ankylosing spondylitis clinical trials currently recruiting in Irving, TX. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Irving?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Irving research site will contact you about next steps.

Are clinical trials in Irving free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Irving studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 5 active trials in Irving are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated July 13, 2026 from ClinicalTrials.gov